Denis Chem Lab
78.37
+1.14(+1.48%)
Market Cap₹108.78 Cr
PE Ratio12.30
IndustryHealthcare
Company Performance:
1D+1.48%
1M0.00%
6M0.00%
1Y0.00%
5Y+44.73%
View Company Insightsright
More news about Denis Chem Lab
13Aug 25
Denis Chem Lab Reports 19% Surge in Q1 Profit, Revenue Grows 4.9%
Denis Chem Lab Limited, a pharmaceutical company, announced strong Q1 FY2026 results. Net profit increased by 19% to Rs 247.50 crore, while revenue from operations grew 4.9% to Rs 4,327.59 crore. Earnings per share rose to Rs 1.78 from Rs 1.50 in the previous year. The company demonstrated effective cost management despite increased material costs. Managing Director Himanshu C. Patel highlighted the company's resilience and operational strength. Auditors Shah & Shah Associates issued an unmodified opinion on the financial results.
 no imag found
Denis Chem Lab
78.37
+1.14
(+1.48%)
1 Year Returns:0.00%
Industry Peers
Sun Pharmaceutical
1,872.70
(+1.34%)
Divis Laboratories
6,714.00
(+0.05%)
Torrent Pharmaceuticals
4,517.10
(+3.11%)
Dr Reddys Laboratories
1,279.90
(-1.08%)
Cipla
1,304.90
(-3.13%)
Lupin
2,255.90
(-5.19%)
Mankind Pharma
2,468.80
(+1.56%)
Zydus Life Science
956.95
(+1.80%)
Aurobindo Pharma
1,486.60
(-0.05%)
Laurus Labs
1,266.80
(+3.13%)